Oral manifestations in inflammatory bowel disease: A cross-sectional study in Isfahan

Background: Various systemic diseases can cause oral manifestations, such as inflammatory bowel disease (IBD). This study is designed to investigate the frequency of oral manifestations in patients with IBD referred to health centers and offices in Isfahan in 2018. Materials and Methods: This cross-...

Full description

Bibliographic Details
Main Authors: Faezeh Khozeimeh, Hadi Shakerin, Hamed Daghaghzadeh, Fereshteh Najarzadegan, Zahra Golestannejad, Peyman Adibi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Dental Research Journal
Subjects:
Online Access:http://www.drjjournal.net/article.asp?issn=1735-3327;year=2021;volume=18;issue=1;spage=4;epage=4;aulast=Khozeimeh
_version_ 1818928613489115136
author Faezeh Khozeimeh
Hadi Shakerin
Hamed Daghaghzadeh
Fereshteh Najarzadegan
Zahra Golestannejad
Peyman Adibi
author_facet Faezeh Khozeimeh
Hadi Shakerin
Hamed Daghaghzadeh
Fereshteh Najarzadegan
Zahra Golestannejad
Peyman Adibi
author_sort Faezeh Khozeimeh
collection DOAJ
description Background: Various systemic diseases can cause oral manifestations, such as inflammatory bowel disease (IBD). This study is designed to investigate the frequency of oral manifestations in patients with IBD referred to health centers and offices in Isfahan in 2018. Materials and Methods: This cross-sectional study was done among 161 patients suffering from IBD in Isfahan, Iran. They were chosen by the systematic randomized sampling. Finally, the data were analyzed using the logistic regression test in the SPSS software. Significance was assigned at P < 0.05. Results: The number of patients with ulcerative colitis and Crohn's syndrome was, respectively, 119 persons (73.9%) and 42 persons (26.1%). Oral manifestations were seen among 52 (32.3%) of the samples. The frequency of oral manifestations was 35.6% (31 cases) in males and 28.4% (21 cases) in females. Oral manifestations were seen in 29.4% of patients with ulcerative colitis and 40.5% of patients with Crohn's disease. Based on the logistic regression, there was a statistically significant relationship between the use of azathioprine and mesalazine with oral manifestations (P < 0.05), whereas the severity of disease and smoking were not statistically significantly related to oral manifestations (P > 0.05). Conclusion: The severity of the disease was not significantly correlated with oral manifestations, which are in agreement with the results of previous studies. It was also found that among patients with IBD, the oral aphthous ulcers can appear 1–3 years before the diagnosis of the disease. Besides that, some of the drugs used to treat the disease have a significant relationship with oral manifestations.
first_indexed 2024-12-20T03:31:42Z
format Article
id doaj.art-67528687629a432cbf346b8f2b6c5404
institution Directory Open Access Journal
issn 1735-3327
2008-0255
language English
last_indexed 2024-12-20T03:31:42Z
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Dental Research Journal
spelling doaj.art-67528687629a432cbf346b8f2b6c54042022-12-21T19:54:58ZengWolters Kluwer Medknow PublicationsDental Research Journal1735-33272008-02552021-01-011814410.4103/1735-3327.310033Oral manifestations in inflammatory bowel disease: A cross-sectional study in IsfahanFaezeh KhozeimehHadi ShakerinHamed DaghaghzadehFereshteh NajarzadeganZahra GolestannejadPeyman AdibiBackground: Various systemic diseases can cause oral manifestations, such as inflammatory bowel disease (IBD). This study is designed to investigate the frequency of oral manifestations in patients with IBD referred to health centers and offices in Isfahan in 2018. Materials and Methods: This cross-sectional study was done among 161 patients suffering from IBD in Isfahan, Iran. They were chosen by the systematic randomized sampling. Finally, the data were analyzed using the logistic regression test in the SPSS software. Significance was assigned at P < 0.05. Results: The number of patients with ulcerative colitis and Crohn's syndrome was, respectively, 119 persons (73.9%) and 42 persons (26.1%). Oral manifestations were seen among 52 (32.3%) of the samples. The frequency of oral manifestations was 35.6% (31 cases) in males and 28.4% (21 cases) in females. Oral manifestations were seen in 29.4% of patients with ulcerative colitis and 40.5% of patients with Crohn's disease. Based on the logistic regression, there was a statistically significant relationship between the use of azathioprine and mesalazine with oral manifestations (P < 0.05), whereas the severity of disease and smoking were not statistically significantly related to oral manifestations (P > 0.05). Conclusion: The severity of the disease was not significantly correlated with oral manifestations, which are in agreement with the results of previous studies. It was also found that among patients with IBD, the oral aphthous ulcers can appear 1–3 years before the diagnosis of the disease. Besides that, some of the drugs used to treat the disease have a significant relationship with oral manifestations.http://www.drjjournal.net/article.asp?issn=1735-3327;year=2021;volume=18;issue=1;spage=4;epage=4;aulast=Khozeimehcolitiscrohn diseaseinflammatory bowel diseaseoral manifestationsulcerative
spellingShingle Faezeh Khozeimeh
Hadi Shakerin
Hamed Daghaghzadeh
Fereshteh Najarzadegan
Zahra Golestannejad
Peyman Adibi
Oral manifestations in inflammatory bowel disease: A cross-sectional study in Isfahan
Dental Research Journal
colitis
crohn disease
inflammatory bowel disease
oral manifestations
ulcerative
title Oral manifestations in inflammatory bowel disease: A cross-sectional study in Isfahan
title_full Oral manifestations in inflammatory bowel disease: A cross-sectional study in Isfahan
title_fullStr Oral manifestations in inflammatory bowel disease: A cross-sectional study in Isfahan
title_full_unstemmed Oral manifestations in inflammatory bowel disease: A cross-sectional study in Isfahan
title_short Oral manifestations in inflammatory bowel disease: A cross-sectional study in Isfahan
title_sort oral manifestations in inflammatory bowel disease a cross sectional study in isfahan
topic colitis
crohn disease
inflammatory bowel disease
oral manifestations
ulcerative
url http://www.drjjournal.net/article.asp?issn=1735-3327;year=2021;volume=18;issue=1;spage=4;epage=4;aulast=Khozeimeh
work_keys_str_mv AT faezehkhozeimeh oralmanifestationsininflammatoryboweldiseaseacrosssectionalstudyinisfahan
AT hadishakerin oralmanifestationsininflammatoryboweldiseaseacrosssectionalstudyinisfahan
AT hameddaghaghzadeh oralmanifestationsininflammatoryboweldiseaseacrosssectionalstudyinisfahan
AT fereshtehnajarzadegan oralmanifestationsininflammatoryboweldiseaseacrosssectionalstudyinisfahan
AT zahragolestannejad oralmanifestationsininflammatoryboweldiseaseacrosssectionalstudyinisfahan
AT peymanadibi oralmanifestationsininflammatoryboweldiseaseacrosssectionalstudyinisfahan